JUN and neoplasm: Plau being responsive to AP-1 in diverse situations (5–10), we have asked here whether it could be a target of Fra-1, as Fra-1, a Fos family member, is recurrently overexpressed in aggressive mammary tumors where it contributes to the tumor phenotype (14,20,31,32).